Goldman Sachs trims Carl Zeiss Meditec stake to 4.86% from 5.39%

• Goldman Sachs cut its total voting rights stake in Carl Zeiss Meditec to 4.86% from 5.39%.
• Holdings via shares slipped to 0.51% from 0.63%.
• Exposure through instruments eased to 4.35% from 4.76%.
• Threshold was crossed on Sep. 17, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2404054_en) on September 23, 2026, and is solely responsible for the information contained therein.